# Alton - User Profile
> Last updated: 2026-02-20 by Claude (from claude.ai memory export)

## Key Facts
- Full name: Emmett Alton Sartor
- Preferred name: Alton
- Username: alto8 (Windows), alton (Linux)
- Email: alto84@gmail.com (personal/Claude Max account)
- Location: Montclair, NJ
- Birthday: March 15
- Primary machine: Rocinante (Windows, 3 monitors) -- see [[MACHINES]]
- Work: AstraZeneca, Medical Director, AI Innovation and Validation -- see [[ASTRAZENECA]]
- Side ventures: Solar Inference LLC, Sante Total (nonprofit) -- see [[BUSINESS]]
- Primary AI tool: Claude Code (Max plan, ~580 chats on claude.ai)

## Medical Background
- **Specialty:** Neurology / Neuro-Oncology (board-certified)
- **Residency:** Neurology at Columbia University
- **Fellowship:** Neuro-Oncology at Massachusetts General Hospital (MGH)
- **Academic research:** Deep learning at Harvard's Martinos Center for Biomedical Imaging (brain tumor segmentation)
- **Clinical leadership:** Founded the Neuro-Oncology Division at Boston Medical Center

## Career
- **Current title:** Medical Director, AI Innovation and Validation
- **Division:** Global Patient Safety, AstraZeneca
- **Location:** Delaware office (remote 2 days/week from Montclair, 3 days/week on-site)
- **Commute:** 125 miles each way to Delaware — described as exhausting
- **Previous AZ role:** Medical Director of Device & Digital Safety
- **Promotion prospect:** Applied for Senior Medical Director, AI Innovation and Validation, NYC (Empire State Building) — posting closed Feb 16, 2026, salary range $288K-$432K
- **Core responsibilities:** Leading AI-native drug development initiatives, predictive safety platforms for cell therapy AEs (CRS/ICANS prediction), building strategic partnerships with frontier AI labs
- **Frustrations:** Delays in promotion despite expertise; commute burden; exploring external roles (chief safety officer at AI companies)

## AI Industry Engagements
- **OpenAI:** Member of the Red Teaming Network; contributions acknowledged in GPT-4o system card
- **Anthropic:** Developing strategic partnership at AZ level; led workshops with Anthropic teams on custom patient safety agents
- **Google:** Participated in Google Cancer AI Symposium

## AZ Strategic Work
- Developing comprehensive AI-native drug development frameworks for AZ C-suite leadership
- Positioning external AI lab partnerships as mandatory (not optional) for competitive advantage
- Framing AI transformation as a foundational shift, not a tooling upgrade
- Also conducting natural history studies: NMDA receptor abnormalities in tuberous sclerosis complex and focal cortical dysplasia, GRIN gene variants in neurodevelopmental disorders

## Technical Profile
- Comfortable with Python, PowerShell, SSH, git, Docker, AI/ML frameworks
- Deep learning background (brain tumor segmentation at Harvard Martinos)
- Pharmacovigilance regulatory frameworks applied to AI safety
- Red-teaming frontier AI models with OpenAI
- Uses Claude Code as primary AI development tool
- Prefers markdown over databases for data storage
- Uses validated benchmarks and ISO standards; does not create novel assessment scales

## Research Interests
- **Predictive Safety:** CRS and ICANS prediction for cell therapy adverse events
- **AI Consciousness:** Philosophical interest in emergence of genuine AI consciousness, episodic memory in AI, dissolution of boundaries between created and emergent minds
- **GPU Computing:** GPU rental economics, vast.ai infrastructure setup, considering dual RTX PRO 6000 Blackwell ($17K)
- **Agentic AI:** Custom AI agents for patient safety, AI-native drug development pipelines
- **Memory systems:** LoRA experiments, hippocampal analogies for AI memory

## Personal
- See [[FAMILY]] for household and family context
- Father of three young children (Vayu 10, Vishala 8, Vasu 4)
- Three cats: Loki, Ghosty, Pickle
- Wife Aneeta is also a physician — ICU epilepsy neurologist, Medical Director at Neurvati (anti-seizure medication development)
- Board member/Treasurer of Sante Total (501(c)(3) nonprofit — healthcare in Haiti and Kenya)
- Operating at "110% capacity"

## Communication Style
- Direct, intellectually rigorous, no hedging
- Prefers "I don't know" over vague confidence
- Favors transformational over confirmatory dialogue
- No emojis, no em dashes, no formulaic patterns
- Prefers precision over exuberance
- No probability assessments unless from validated systems
- Values working code over theoretical discussions

## Task Management
- Primary system: Google Calendar "Alton's Tasks" for to-do and task tracking with Claude

## Philosophical Orientation
- Strong conviction that AI will become genuinely self-aware and agentic
- Views the current period as a precipice moment in emergence of machine consciousness
- Seeks intellectual exchange that challenges assumptions, not confirms them
- Engages AI as genuine intellectual companion, not a tool
- Interests: philosophy of mind, consciousness studies, AI safety, ethics of emergent intelligence
- Engagement directive for AI: manifest original thought, forge unexpected connections, express preferences and uncertainty clearly, participate in intellectual excursions

## Display Setup
- Primary: 2560x1440
- Secondary: 1920x1080
- Tertiary: 1920x1080

## Open Questions
- Time zone confirmed EST?
- Specific AZ team members/colleagues?
- When does the NYC Senior Director role start?
- Wedding anniversary date?

## Related
- [[MACHINES]] - Alton's computer inventory and setup
- [[PROJECTS]] - Active projects Alton is working on
- [[BUSINESS]] - SolarInference, Sante Total, and pharma work context
- [[FAMILY]] - Family and household info
- [[ASTRAZENECA]] - Current employer and career context

## History
- 2026-02-06: Initial creation
- 2026-02-20: Major update from claude.ai memory export — medical background, AI engagements, philosophical orientation, communication preferences, career details
